Cargando…

Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist

BACKGROUND AND PURPOSE: Developmental switches in NMDA receptor subunit expression have been inferred from studies of GluN2 expression levels, changes in kinetics of glutamatergic synaptic currents and sensitivity of NMDA receptor-mediated currents to selective GluN2B antagonists. Here we use TCN 21...

Descripción completa

Detalles Bibliográficos
Autores principales: McKay, S, Griffiths, NH, Butters, PA, Thubron, EB, Hardingham, GE, Wyllie, DJA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417419/
https://www.ncbi.nlm.nih.gov/pubmed/22022974
http://dx.doi.org/10.1111/j.1476-5381.2011.01748.x
_version_ 1782240499617234944
author McKay, S
Griffiths, NH
Butters, PA
Thubron, EB
Hardingham, GE
Wyllie, DJA
author_facet McKay, S
Griffiths, NH
Butters, PA
Thubron, EB
Hardingham, GE
Wyllie, DJA
author_sort McKay, S
collection PubMed
description BACKGROUND AND PURPOSE: Developmental switches in NMDA receptor subunit expression have been inferred from studies of GluN2 expression levels, changes in kinetics of glutamatergic synaptic currents and sensitivity of NMDA receptor-mediated currents to selective GluN2B antagonists. Here we use TCN 213, a novel GluN2A-selective antagonist to identify the presence of this subunit in functional NMDA receptors in developing cortical neurones. EXPERIMENTAL APPROACH: Two-electrode voltage-clamp (TEVC) recordings were made from Xenopus laevis oocytes to determine the pharmacological activity of TCN 213 at recombinant NMDA receptors. TCN 213 antagonism was studied in cultures of primary cortical neurones, assessing the NMDA receptor dependency of NMDA-induced excitotoxicity and monitoring developmental switches in NMDA receptor subunit composition. KEY RESULTS: TCN 213 antagonism of GluN1/GluN2A NMDA receptors was dependent on glycine but independent of glutamate concentrations in external recording solutions. Antagonism by TCN 213 was surmountable and gave a Schild plot with unity slope. TCN 213 block of GluN1/GluN2B NMDA receptor-mediated currents was negligible. In cortical neurones, at a early developmental stage predominantly expressing GluN2B-containing NMDA receptors, TCN 213 failed to antagonize NMDA receptor-mediated currents or to prevent GluN2B-dependent, NMDA-induced excitoxicity. In older cultures (DIV 14) or in neurones transfected with GluN2A subunits, TCN 213 antagonized NMDA-evoked currents. Block by TCN 213 of NMDA currents inversely correlated with block by ifenprodil, a selective GluN2B antagonist. CONCLUSIONS AND IMPLICATIONS: TCN 213 selectively blocked GluN1/GluN2A over GluN1/GluN2B NMDA receptors allowing direct dissection of functional NMDA receptors and pharmacological profiling of developmental changes in native NMDA receptor subunit composition.
format Online
Article
Text
id pubmed-3417419
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-34174192012-11-09 Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist McKay, S Griffiths, NH Butters, PA Thubron, EB Hardingham, GE Wyllie, DJA Br J Pharmacol Research Papers BACKGROUND AND PURPOSE: Developmental switches in NMDA receptor subunit expression have been inferred from studies of GluN2 expression levels, changes in kinetics of glutamatergic synaptic currents and sensitivity of NMDA receptor-mediated currents to selective GluN2B antagonists. Here we use TCN 213, a novel GluN2A-selective antagonist to identify the presence of this subunit in functional NMDA receptors in developing cortical neurones. EXPERIMENTAL APPROACH: Two-electrode voltage-clamp (TEVC) recordings were made from Xenopus laevis oocytes to determine the pharmacological activity of TCN 213 at recombinant NMDA receptors. TCN 213 antagonism was studied in cultures of primary cortical neurones, assessing the NMDA receptor dependency of NMDA-induced excitotoxicity and monitoring developmental switches in NMDA receptor subunit composition. KEY RESULTS: TCN 213 antagonism of GluN1/GluN2A NMDA receptors was dependent on glycine but independent of glutamate concentrations in external recording solutions. Antagonism by TCN 213 was surmountable and gave a Schild plot with unity slope. TCN 213 block of GluN1/GluN2B NMDA receptor-mediated currents was negligible. In cortical neurones, at a early developmental stage predominantly expressing GluN2B-containing NMDA receptors, TCN 213 failed to antagonize NMDA receptor-mediated currents or to prevent GluN2B-dependent, NMDA-induced excitoxicity. In older cultures (DIV 14) or in neurones transfected with GluN2A subunits, TCN 213 antagonized NMDA-evoked currents. Block by TCN 213 of NMDA currents inversely correlated with block by ifenprodil, a selective GluN2B antagonist. CONCLUSIONS AND IMPLICATIONS: TCN 213 selectively blocked GluN1/GluN2A over GluN1/GluN2B NMDA receptors allowing direct dissection of functional NMDA receptors and pharmacological profiling of developmental changes in native NMDA receptor subunit composition. Blackwell Publishing Ltd 2012-06 /pmc/articles/PMC3417419/ /pubmed/22022974 http://dx.doi.org/10.1111/j.1476-5381.2011.01748.x Text en © 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society
spellingShingle Research Papers
McKay, S
Griffiths, NH
Butters, PA
Thubron, EB
Hardingham, GE
Wyllie, DJA
Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist
title Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist
title_full Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist
title_fullStr Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist
title_full_unstemmed Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist
title_short Direct pharmacological monitoring of the developmental switch in NMDA receptor subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist
title_sort direct pharmacological monitoring of the developmental switch in nmda receptor subunit composition using tcn 213, a glun2a-selective, glycine-dependent antagonist
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417419/
https://www.ncbi.nlm.nih.gov/pubmed/22022974
http://dx.doi.org/10.1111/j.1476-5381.2011.01748.x
work_keys_str_mv AT mckays directpharmacologicalmonitoringofthedevelopmentalswitchinnmdareceptorsubunitcompositionusingtcn213aglun2aselectiveglycinedependentantagonist
AT griffithsnh directpharmacologicalmonitoringofthedevelopmentalswitchinnmdareceptorsubunitcompositionusingtcn213aglun2aselectiveglycinedependentantagonist
AT butterspa directpharmacologicalmonitoringofthedevelopmentalswitchinnmdareceptorsubunitcompositionusingtcn213aglun2aselectiveglycinedependentantagonist
AT thubroneb directpharmacologicalmonitoringofthedevelopmentalswitchinnmdareceptorsubunitcompositionusingtcn213aglun2aselectiveglycinedependentantagonist
AT hardinghamge directpharmacologicalmonitoringofthedevelopmentalswitchinnmdareceptorsubunitcompositionusingtcn213aglun2aselectiveglycinedependentantagonist
AT wylliedja directpharmacologicalmonitoringofthedevelopmentalswitchinnmdareceptorsubunitcompositionusingtcn213aglun2aselectiveglycinedependentantagonist